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Abstract 
The cytoplasmic Ca 2+ concentration ([Ca 2+ ]i) was continuously monitored in single glucagon-producing a2-cells isolated from the 
mouse pancreas and later identified by immunostaining. Up to 60% of the a2-cells exhibited spontaneous [Ca 2+ ]i oscillations (frequency 
0.1-0.3/min) in a medium containing 3 mM glucose. In originating from a basal evel of 60-100 nM, reaching peak values of 300-400 
nM and promptly disappearing after blocking voltage-dependent Ca 2+ channels with methoxyverapamil, theoscillations resembled those 
in insulin-releasing /3-cells stimulated by glucose. The oscillatory activity was suppressed when combining elevation of glucose to 20 
mM with the addition of 2-2000 ng/ml insulin. Whereas 10 mM of L-arginine or L-glycine transformed the oscillations into sustained 
elevation of [Ca 2+ ]i, there was no response to 1 mM tolbutamide or 0.1-1 mM y-aminobutyric a id. The observations that ce2-cells differ 
from islet cells secreting insulin and somatostatin i  responding to adrenaline with mobilisation of intracellular calcium can be used for 
their rapid identification. It is suggested that the oscillations reflect periodic entry of Ca 2+ due to variations of the membrane potential. 
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1. Introduction 
There are various types of evidence that Ca 2+ has a key 
role in stimulus-secretion coupling of glucagon-producing 
a2-cells. The secretory activity is enhanced by the Ca 2÷ 
ionophore A-23187 [1,2], and in islets permeabilized with 
digitonin a rise of Ca 2÷ stimulates the release of glucagon 
in a concentration-dependent manner [3]. Studies of iso- 
lated a2-cells have further supported the importance of 
Ca 2÷ in demonstrating CaZ+-dependent action potentials 
[4,5] and that modulators of secretion induce changes of 
the cytoplasmic Ca 2+ concentration ([Ca2+]i) consistent 
with their actions on glucagon release [6,7]. 
Like other islet hormones the plasma concentrations of 
glucagon are known to vary in a cyclic fashion due to 
pulsatile secretion [8,9]. In the case of insulin this periodic- 
ity can be accounted for by synchronisation of an oscilla- 
tory Ca 2+ signal among /3-cells [10,11]. There are reasons 
to believe that there is similar coordination of normal 
c~2-cells, since it was recently demonstrated that also these 
cells have an intrinsic ability to generate [Ca2+]i oscilla- 
tions [ 12]. 
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The discovery of oscillations in normal a2-cells raises 
several questions about the regulation of glucagon release. 
An important one is how modulators of the secretory 
activity affect the [Ca2+] i oscillations. In the present study 
it will be shown that a high concentration of glucose in 
combination with insulin has a suppressive ffect and that 
the amino acids glycine and arginine transform the oscilla- 
tions into a sustained elevation of [Ca2+]~. 
2. Materials and methods 
Islets of Langerhans were isolated with the aid of 
collagenase from the pancreatic glands (avoiding the duo- 
denal portion) of 10- to 12-week-old female NMRI mice. 
Single cells were prepared by shaking the islets in a 
Ca2+-deficient medium [ 13]. After centrifugation through 
RPMI 1640 medium containing 10% foetal calf serum, 100 
IU /ml  penicillin and 100 /~g/ml gentamicin, the cells 
were suspended and allowed to attach to circular 25-mm 
cover glasses and kept overnight at 37°C in an atmosphere 
of 5% CO 2 in humidified air. 
The subsequent experimental handling was performed 
with a basal medium physiologically balanced in cations 
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with CI- as the sole anion [14]. This medium was supple- 
mented with 0.5 mg/ml bovine serum albumin and con- 
tained 3 mM glucose as well as 2.56 mM Ca 2+. After 
rinsing, the cells were loaded with 0.5/xM fura-2 acetoxy- 
methyl ester during 30-40 min incubation at 37°C. The 
cover glasses with the attached cells were then washed and 
used as the bottom of an open chamber designed for 
microscopic work [15]. The chamber wall was a broad 
silicon rubber ring (9 mm inner diameter) pressed to the 
cover glass by the threaded chamber mount and a thin 
stainless teel ring. Cannulas fixed to this ring were con- 
nected to a two-channel peristaltic pump allowing steady 
superfusion of a 2.5 mm medium layer at a rate of 0.75 
ml/min. The chamber was placed on the stage of an 
inverted microscope (Nikon Diaphot) within a climate box 
maintained at 37°C. The microscope was equipped for 
epifluorescence fluorometry with a 400 nm dichroic mirror 
and a 40 × Fluor oil immersion objective. 
A 75 W xenon arc lamp and 10-13 nm half-band-width 
interference filters were used for excitation. Images were 
collected through a 30 nm half-band-width filter at 510 nm 
with an intensified CCD camera (Extended ISIS-M, Photo- 
tonic Science, Robertsbridge, UK). The excitation filter 
changer was part of a Magiscan image analysis system 
(Applied Imaging, Gateshead, UK). The amplification of 
the intensified video camera was set to utilise optimally 
the dynamic range of the analogue-to-digital converter at 
either wavelength or any [Ca2+]i level encountered. The 
specimens were illuminated only during image capture. 
Photodamage of the cells was minimised with neutral 
density filters. Calibration was performed according to 
previously described procedures [16]. The Tardis program 
(Applied Imaging) was used for the image analysis. All 
340/380 nm ratio frames were calculated after subtraction 
of background frames. The calculations were based on 
capture of an image pair every 3.4-8.4 s. Each image 
consisted of 16 accumulated video frames divided by 8, 
the time between the averaged 340 and 380 nm images 
being 1.1 s. 
Measurements of [Ca 2+ ]i were followed by immuno- 
staining for glucagon with the cells remaining in position 
in the perifusion chamber on the microscope stage. The 
cells were fixed during 5 min exposure to 95% ethanol, 
rinsed with distilled water and then stained with peroxi- 
dase anti-peroxidase t chnique. Studying the effects of 
adrenaline this substance was also tested on cells stained 
with a similar protocol for insulin and somatostatin. 
Reagents of analytical grade and deionized water were 
used. Collagenase, HEPES and bovine serum albumin 
(fraction V) were obtained from Boehringer Mannheim 
GmbH (Mannheim, Germany). Antibodies for the PAP 
immunostaining and adrenaline were products of DAKO 
Corp (Carpinteria, CA) and Sigma Chemical Co (St. Louis, 
MO) respectively. Fura-2 acetoxymethyl ester was from 
Molecular Probes Inc. (Eugene, OR), methoxyverapamil 
was donated by Knoll AG (Ludwigshafen am Rhein, Ger- 
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Fig. 1. Effects of raising the glucose concentration from 3 to 20 mM on 
[ Ca2+ ]i oscillations in two ot2-cells. Representative of 9 cells. 
many) and porcine monocomponent insulin was a gift 
from Novo Nordisk A /S  (Bagsvaerd, Denmark). 
3. Results 
Up to 60% of the a2-cells displayed spontaneous [Ca 2+ ]i 
oscillations (frequency 0.1-0.3/min) in the presence of 3 
mM glucose. The oscillations originated from a basal level 
of 60-I00 nM and reached peak values of 300-400 nM 
(Fig. 1). When raising the glucose concentration to 20 mM 
the oscillations continued but were often temporarily inter- 
rupted. When the glucose concentration was maintained at 
3 mM the addition of 2-2000 ng/ml insulin had a similar 
weak tendency to interrupt he oscillations (not shown). 
However, when combining 20 mM glucose with 2-2000 
ng/ml insulin the oscillations were partially (Fig. 2A) or 
completely (Fig. 2B) suppressed. Whereas the oscillatory 
activity was unaffected by 100 /~M y-aminobutyric acid 
(GABA), [Ca2--]i was rapidly lowered to basal levels by 
50 /zM methoxyverapamil (not shown). 
Although differing with regard to their oscillatory activ- 
ity the t~2-cells responded to adrenaline with increase of 
[Ca2t]i after pre-exposure to 20 mM glucose. Such a 
response, manifested either as a single peak or oscillations, 
was always seen irrespective of whether the voltage-depen- 
dent Ca ~+ channels were blocked (n = 5) or not (n = 24) 
by methoxyverapamil (Fig. 3, panels A-C). Comparing 
the reactions of different islet cells, later identified with 
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Fig. 2. Effects of combining rise of glucose with addition of insulin on 
[ Ca2÷ ]i oscillations in an ce2-cell. The arrows indicate the additions of 20 
ng/ml  insulin and the bars the glucose concentration. Suppression of the 
oscillatory activity during a prolonged period of time (panel B) was seen 
in 4 out of 10 cells. 
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Fig. 4. Effects of L-glycine and L-arginine on [Ca 2+ ]i oscillations in
a2-cells. The arrows indicate the additions of 10 mM of either L-glycine 
(GLY) or L-arginine (ARG), 50/xM methoxyverapamil (MV) and 3 /xM 
adrenaline (ADR). The bars denote the periods for the presence of 3 or 20 
mM glucose and 100 /~M or 1 mM y-aminobutyric acid (GABA). 
Representative of 5 cells exposed to each amino acid. 
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Fig. 3. Recordings of [Ca 2+ ]i in ot2-cells exposed to adrenaline or 
tolbutamide. The arrows indicate the additions of 3 /~M adrenaline 
(ADR) in the presence of 20 mM glucose or 1 mM tolbutamide (TOL) in 
the presence of 3 mM glucose. Panels A, B and D refer to experiments 
with non-oscillating o~2-cells. In panel C the oscillations were prevented 
by the presence of 50 /xM methoxyverapamil. Representative r sponses 
for 19 (A) and 5 (B) out of 24 cells and for 5 cells (C,D). 
immunostaining, it became apparent hat neither those 
positive for insulin nor for somatostatin responded to 
adrenaline with increase of [Ca2+]+. Tolbutamide lacked 
effect on [Ca2+]i both in oscillating (n =4;  not shown) 
and non-oscillating (n = 5) c~2-cells (Fig. 3, panel D). 
L-glycine or L-arginine had profound effects on sponta- 
neously oscillating ae-cells. At concentrations of 10 mM 
these amino acids induced initial peaks of [Ca 2÷ ]~ fol- 
lowed by sustained elevation (Fig. 4). GABA had little 
effect on the sustained elevation of [Ca2+]i in response to 
L-arginine. 
4. Discussion 
Early studies of individual c~2-cells from guinea pigs 
[6,7] and rats [17] did not show oscillations of [Ca2+] i. It 
has therefore been suggested that the pulsatile release of 
glucagon requires the transfer of oscillatory Ca e÷ signals 
from adjacent /3-cells [18]. Recent observations of sponta- 
neous [Ca2+] i oscillations in single cells of a clonal 
glucagon-secreting hamster cell line [19] as well as in 
normal mouse c~2-cells [12] call for a reconsideration f
this idea. Failure to demonstrate oscillations might simply 
result from disturbances related to the cell handling. The 
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possibility that methodological inadequacies prevent he 
appearance of [Ca 2+ ]i oscillations is well illustrated from 
studies of/3-cells. With improved techniques for isolation 
and efforts to minimise the exposure to UV-light, we have 
seen a considerable increase in the percentage of /3-cells 
responding to glucose with large amplitude [Ca 2+ ]i oscilla- 
tions [10]. 
The spontaneous o cillations of [Ca 2+ ]i in the az-cells 
resembled those induced by glucose in /3-cells [10] with 
regard to frequency and amplitude and in originating from 
close to basal levels. Another similarity was their suppres- 
sion with methoxyverapamil [12]. In this respect he c~ 2- 
cells differ from clonal glucagon-secreting cells, which 
have been reported to be insensitive to blockers of 
voltage-dependent Ca 2+ channels [19]. It is pertinent o 
note that the az-cells, unlike the/3-cells, do not respond to 
the sulfonylurea tolbutamide. There are convincing reports 
that clonal glucagon-releasing cells are equipped with 
ATP-regulated K + channels sensitive to sulfonylureas 
[20,21], but no such channels have been found in unequiv- 
ocally identified normal tee-cells. It was reported in an 
abstract [22] that tolbutamide-sensitive whole cell K + 
currents occur in a rat islet population rich in a2-cells, but 
another study of a similar preparation [4] or measurements 
on the large az-cells from guinea pigs [5] have failed to 
demonstrate a K + conductance regulated by ATP. The 
present studies provide additional support that c~2-cells 
lack functional K + channels regulated by ATP by showing 
that [Ca 2+]i remains unaffected when oscillating or non- 
oscillating az-cells are exposed to tolbutamide. 
Previous studies have indicated cAMP mobilisation of 
Ca 2+ incorporated into the a2-cells in response to glucose 
[7]. An effective means of raising cAMP and stimulating 
glucagon release is to activate /3-adrenergic receptors with 
adrenaline [23]. By interacting with the ~x2-adrenergic 
receptors this agonist inhibits the release of the other major 
islet hormones insulin and somatostatin [23,24]. The pre- 
sent data indicate that among mouse islet cells secreting 
insulin, somatostatin and glucagon, only the latter respond 
to adrenaline with increase of [Ca2+]~. Accordingly, the 
addition of adrenaline at the end of an experiment can be 
used as a functional test for rapid identification of c~2-cells. 
Whereas increase of the blood sugar level is associated 
with suppression of glucagon secretion in healthy subjects, 
type-1 diabetic patients have elevated glucagon levels de- 
spite hyperglycaemia [25]. The abnormal glucose response 
of the c~2-celts in diabetes has been attributed to the 
deficiency of insulin [26,27], but this idea has not received 
general acceptance. It has for example been difficult to 
demonstrate an influence of insulin both on glucagon 
release from purified a2-cells [28] and on their electrical 
activity [5]. Our early studies of guinea pig c~2-cells pro- 
vided evidence for a mechanism by which glucose may 
inhibit glucagon release by indicating sugar-induced re- 
moval of Ca 2 + from the cytoplasm resulting in lowering of 
[Ca2+]i [6,7]. Although activation of Ca 2+ removal from 
the cytoplasm has been found to suppress [Ca 2+ ]i oscilla- 
tions in /3-cells [29], we now found that elevation of 
glucose alone has only weak effects on the spontaneous 
[Ca2+]i oscillations in Cez-cells. Interestingly, the oscilla- 
tions were more effectively suppressed when combining 
the rise of glucose with insulin concentrations supposed to 
exist within islets [30]. 
In the pancreatic /3-cell the glucose-induced slow 
[ Ca2+ ]i oscillations apparently reflect repetitive depolarisa- 
tions resulting in periodic entry of Ca 2+ through voltage- 
dependent channels [10]. Using thapsigargin for depletion 
of the Ca 2+ stores as well as Ba 2+ as an analogue for 
Ca ~-+, we have recently demonstrated that these oscilla- 
tions can occur without involvement of the endoplasmic 
reticulum [31]. The spontaneous oscillations of [Ca 2 + ]i in 
the az-cells may also result from periodic opening of 
voltage-dependent Ca 2+ channels, since they were 
promptly inhibited by methoxyverapamil. However, it is 
difficult to exclude the contribution of Ca 2 + mobilisation 
from intemal stores. Studies of such a contribution are 
much more demanding than in the more abundant /3-cells. 
Previous patch clamp studies [5] revealed that az-cells 
have Ca2+-dependent action potentials under basal condi- 
tions, whose frequency is markedly increased in response 
to minor depolarisation. Electrogenic entry of the posi- 
tively charged amino acid L-arginine thus increased the 
number of action potentials. The present study confirms 
the reports of a sustained elevation of [Ca 2+ ]i in a2-cells 
exposed to L-arginine [6,7]. The effect of L-arginine on 
[ Ca2+ ]i was mimicked by L-glycine, which has depolaris- 
ing actions in being cotransported with Na +. In glucose- 
stimulated /3-cells, L-glycine induces a similar transforma- 
tion of the [Ca2+]~ oscillations into sustained elevation 
[32]. It has been reported that GABA activates an inward 
CI- current in guinea pig ce2-cells, resulting in hyperpolar- 
isation [33]. Although GABA has a slight inhibitory effect 
on glucagon release from mouse islets [34], its action was 
not sufficiently pronounced to counteract the spontaneous 
oscillations or the sustained increase of [Ca 2+ ]~ in mouse 
a2-cells exposed to arginine. 
The significance of energy metabolism for the secretory 
activity of the a2-cells is emphasised not only from the 
inhibitory action of glucose and related sugars [35] but also 
from reports that exposure to metabolic inhibitors [36] and 
lowering of the oxygen tension [37] stimulate glucagon 
release. In the pancreatic /3-cell there is experimental 
evidence indicating that the slow [Ca2+]~ oscillations re- 
flect periodic depolarisations due to fluctuations in the 
ATP production [38]. Since the c~2-cells apparently lack 
ATP-regulated K + channels, it is less obvious how varia- 
tions of metabolism can be linked to the potential-depen- 
dent entry of Ca 2+. Contrary to the situation in /3-cells,the 
available data indicate that Ca 2+ entry into the a2-cells is 
inversely related to the energy production. Since the elec- 
trical activity of az-cells is very sensitive to changes of the 
membrane potential [5], a minor hyperpolarisation btained 
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by ATP activation of electrogenic membrane transporters, 
such as the Na +/K ÷ pump, may be sufficient o close the 
voltage-dependent Ca 2÷ channels and inhibit glucagon 
release. 
Since gap junctions are present between /3- and a 2- 
cells, it has been suggested that the latter cells have 
oscillations determined by the /3-cells [18]. The discovery 
of an intrinsic rhythmic activity in the c~2-cells draws 
attention to the possibility that o~2-cells can act as pace- 
makers for oscillations in adjacent /3-cells. Future studies 
will have to determine whether such a mechanism can 
explain oscillations in basal insulin secretion and resulting 
periodic variations of the circulating hormone in fasting 
subjects [39]. 
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